Celiac Disease Diagnosis and Management

Diagnostic Approach

The American Gastroenterological Association recommends that the diagnostic approach for celiac disease begins with IgA tissue transglutaminase antibody (tTG-IgA) testing while the patient is on a gluten-containing diet, followed by intestinal biopsy for confirmation, and treatment consists of a strict lifelong gluten-free diet 1
The primary screening test is tTG-IgA with high sensitivity (90-96%) and specificity (>95%) 1
Total IgA levels should be measured to rule out IgA deficiency, with a strength of evidence rated as high 2, 1
Testing must be performed while the patient is on a gluten-containing diet (at least 10g daily for 6-8 weeks) 1, 3
In patients with high tTG-IgA levels (>10x upper limit of normal), IgA endomysial antibody (EMA-IgA) should be performed as a confirmatory test with excellent specificity (99.6%) 2, 1

Intestinal biopsy remains the gold standard for diagnosis in adults, with a strength of evidence rated as high 2, 1
Multiple biopsy specimens (ideally 6) should be taken from the second part of the duodenum or beyond 1, 4
Characteristic histologic findings include villous atrophy, crypt lengthening, and increased intraepithelial lymphocytes 1
In adults with tTG-IgA >10x upper limit of normal plus positive EMA-IgA, the positive predictive value for celiac disease approaches 100%, though biopsy may still be performed for differential diagnosis 2

In IgA-deficient patients, IgG-based tests should be used (IgG deamidated gliadin peptide or IgG tTG) 2, 1
HLA-DQ2 and HLA-DQ8 testing has high negative predictive value and is useful when celiac disease is strongly suspected despite negative serology 1, 4
In children with tTG-IgA ≥10× upper limit of normal, positive EMA-IgA, and positive HLA, biopsy may be avoided according to recent guidelines from the American Academy of Pediatrics 1

Patients should be referred to a dietitian experienced in celiac disease management, as recommended by the American Gastroenterological Association 4
Follow-up serology should be performed at 6 and 12 months after diagnosis, and yearly thereafter, with a strength of evidence rated as moderate 2
Negative serology after treatment does not guarantee intestinal mucosal healing 2
Persistently positive serology usually indicates ongoing intestinal damage and continued gluten exposure 2
Patients with persistent or relapsing symptoms should undergo repeat endoscopic biopsies to determine healing, even with negative tTG-IgA, as recommended by the American Gastroenterological Association 2

First-degree relatives of patients with celiac disease should be tested, as recommended by the American Gastroenterological Association 1, 3
Patients with type 1 diabetes mellitus should be tested, with a strength of evidence rated as moderate 1
Patients with unexplained iron deficiency anemia should be tested, as recommended by the American Gastroenterological Association 1, 3
Patients with premature osteoporosis should be tested, with a strength of evidence rated as low 1, 3
Patients with autoimmune thyroid disease should be tested, as recommended by the American Gastroenterological Association 1, 3
Patients with unexplained liver transaminase elevations should be tested, with a strength of evidence rated as low 1
Patients with Down syndrome should be tested, as recommended by the American Academy of Pediatrics 1

Initiating a gluten-free diet before completing diagnostic testing can lead to false-negative results, with a strength of evidence rated as high 4, 3
Relying solely on serology without biopsy confirmation can lead to misdiagnosis, as warned by the American Gastroenterological Association 4, 3
IgG isotype testing for tTG antibody is not specific in the absence of IgA deficiency, with a strength of evidence rated as moderate 2
Seronegative celiac disease can occur and requires biopsy for diagnosis, as noted by the American Gastroenterological Association 3
Patients who have already started a gluten-free diet prior to diagnosis should resume a normal diet with three slices of wheat bread daily for 1-3 months before repeat testing, as recommended by the American Gastroenterological Association 2

The American Gastroenterological Association recommends obtaining multiple specimens—ideally 6 biopsies total: 1-2 from the duodenal bulb and at least 4 from the second part of the duodenum or beyond, to increase diagnostic accuracy 5
In children under 2 years, combining tTG-IgA with IgG and IgA deamidated gliadin peptides improves sensitivity, according to the American Academy of Family Physicians 6
The American Academy of Family Physicians suggests that IgG-based tests, such as IgG deamidated gliadin peptide (DGP-IgG) or IgG tissue transglutaminase (tTG-IgG), are markedly less accurate in patients with normal IgA levels and should not be used in that setting 5

HLA-DQ2 and HLA-DQ8 testing has >99% negative predictive value—absence of both alleles essentially rules out celiac disease, as stated by the American Academy of Family Physicians 6
The American Gastroenterological Association recommends that HLA testing is useful when celiac disease is strongly suspected despite negative serology, in patients with equivocal biopsy findings, or in patients already on a gluten-free diet who were never properly tested 5

For patients with negative serology but high clinical suspicion, the American Gastroenterological Association recommends confirming patient is consuming adequate gluten, verifying total IgA level is normal, and performing HLA-DQ2/DQ8 testing—if positive, proceed to biopsy 5
The American Academy of Family Physicians suggests that in patients already on a gluten-free diet, resuming normal diet with three slices of wheat bread daily for 1-3 months before repeat testing may be necessary, and some patients may require several years of gluten challenge for histologic relapse to occur 5